newsfilter
← Latest News
Business Wire·

Thermo Fisher Scientific Highlights Industry Leadership, Growth Outlook and Long-Term Value Creation at 2026 Investor Day

  • Thermo Fisher Scientific Inc. hosted its annual Investor Day led by Chairman & CEO Marc N. Casper to highlight industry leadership & growth strategies.
  • The company serves an attractive $255 billion market fueled by enduring long-term trends & improving demand.
  • Thermo Fisher leverages its unique scale, depth of capabilities, & a proven commercial engine to gain market share & act as a trusted partner.
  • The Practical Process Improvement (PPI) Business System drives operational excellence, quality, & customer allegiance across the organization.
  • Artificial Intelligence is positioned as a powerful accelerator for scientific breakthroughs, drug discovery productivity, & future growth.
  • The company maintains a disciplined approach to capital deployment through strategic M&A & shareholder returns to strengthen industry leadership.
  • Thermo Fisher targets a long-term organic revenue CAGR of 7% & low-teens adjusted EPS growth.
  • The company's global team supports customers across life sciences, diagnostics, & pharmaceutical services using industry-leading brands.
  • The press release includes standard forward-looking statements & non-GAAP financial measure definitions regarding adjusted EPS & organic revenue growth.